Company Filing History:
Years Active: 1984-1995
Title: The Innovative Contributions of Agnes G Grouhel
Introduction
Agnes G Grouhel is a prominent inventor based in Meudon, France. She has made significant contributions to the field of therapeutics, holding a total of 11 patents. Her work focuses on the development of innovative compounds that have practical applications in medicine.
Latest Patents
Among her latest patents is the invention of allylaminoesters and their application in therapeutics. This patent details allylaminoesters of the formula (I), where R1 can be hydrogen or a low-molecular-weight alkyl. Another notable patent addresses the analgesic properties of fedotozine, which outlines a process for treating painful syndromes through the parenteral or topical administration of a therapeutically effective quantity of the (-) tartrate of (+)-(R)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine.
Career Highlights
Throughout her career, Agnes has worked with various companies, including Jouveinal and Sipsy. Her innovative spirit and dedication to research have led to advancements in therapeutic applications, showcasing her expertise in the field.
Collaborations
Agnes has collaborated with notable individuals such as Jean-Louis Junien and Gilbert G Aubard. These partnerships have contributed to her success and the development of her patented inventions.
Conclusion
Agnes G Grouhel's contributions to the field of therapeutics through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the medical community positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.